Segment Reporting - Schedule of Segment Loss, Including Significant Segment Expenses (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Segment Reporting [Line Items] | ||||||
| Total revenue, net | $ 45,689 | $ 20,923 | $ 71,907 | $ 29,905 | ||
| Less: | ||||||
| Cost of sales | (20,468) | (24,445) | (45,036) | (42,396) | ||
| Loss from operations | (43,838) | (61,217) | (103,351) | (126,457) | ||
| Other income, net | 181 | 135 | 281 | 262 | ||
| Foreign exchange gains (losses), net | 460 | 1,499 | (2,207) | 2,680 | ||
| Interest income | 1,877 | 5,234 | 4,346 | 11,371 | ||
| Interest expense, net | 2,674 | 6,829 | (8,450) | (3,314) | ||
| Income tax expenses | (465) | (397) | (1,328) | (2,623) | ||
| Net loss | (39,111) | $ (71,598) | (47,917) | $ (70,161) | (110,709) | (118,081) |
| Product revenue, net | ||||||
| Segment Reporting [Line Items] | ||||||
| Total revenue, net | 45,672 | 20,923 | 71,890 | 29,905 | ||
| License revenue | ||||||
| Segment Reporting [Line Items] | ||||||
| Total revenue, net | 17 | 0 | 17 | 0 | ||
| Reportable Segment | ||||||
| Segment Reporting [Line Items] | ||||||
| Total revenue, net | 45,689 | 20,923 | 71,907 | 29,905 | ||
| Less: | ||||||
| Cost of sales | (20,468) | (24,445) | (45,036) | (42,396) | ||
| Research and clinical development | (12,236) | (16,069) | (23,191) | (29,120) | ||
| Product delivery | (11,641) | (4,392) | (19,378) | (9,965) | ||
| Commercial and Medical affairs | (17,318) | (15,558) | (35,737) | (31,955) | ||
| Support functions | (18,613) | (18,927) | (38,843) | (36,823) | ||
| Other segment income (expenses), net | (9,251) | (2,749) | (13,073) | (6,103) | ||
| Total operating expenses | (89,527) | (82,140) | (175,258) | (156,362) | ||
| Loss from operations | (43,838) | (61,217) | (103,351) | (126,457) | ||
| Other income, net | 181 | 135 | 281 | 262 | ||
| Foreign exchange gains (losses), net | 460 | 1,499 | (2,207) | 2,680 | ||
| Interest income | 1,877 | 5,234 | 4,346 | 11,371 | ||
| Interest expense, net | 2,674 | 6,829 | (8,450) | (3,314) | ||
| Income tax expenses | (465) | (397) | (1,328) | (2,623) | ||
| Net loss | (39,111) | (47,917) | (110,709) | (118,081) | ||
| Reportable Segment | Product revenue, net | ||||||
| Segment Reporting [Line Items] | ||||||
| Total revenue, net | 45,672 | 20,923 | 71,890 | 29,905 | ||
| Reportable Segment | License revenue | ||||||
| Segment Reporting [Line Items] | ||||||
| Total revenue, net | $ 17 | $ 0 | $ 17 | $ 0 | ||
| X | ||||||||||
- Definition Commercial And Medical Expense No definition available.
|
| X | ||||||||||
- Definition Product Delivery Expense No definition available.
|
| X | ||||||||||
- Definition Research And Clinical Development Expenses No definition available.
|
| X | ||||||||||
- Definition Support Functions Costs No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|